What happened Quince Therapeutics, Inc. (NASDAQ: QNCX) said it changed its name to IRulya Therapeutics Inc. effective at 4:01 p.m. Eastern Time on October 9, 2026. The common stock is expected to begin trading on the Nasdaq Capital Market under IRLA on October 12, 2026. The filing says Brigette Roberts, M.D., became chief executive officer